Clinical Trials in Salt Lake City

Showing 5081-5100 of 16,694 trials

A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants

NCT06704763

The purpose of this study is to determine the effect of quinidine on the levels of orforglipron in the blood stream and how long it takes the body to eliminate it, when administered orally in healthy participants. The study will last up to approximately 8 weeks including screening.

Healthy

Eli Lilly and Company27 participantsStarted Dec 2024

Salt Lake City, Utah, United States

COMPLETEDPhase 1/2< 1 mile

Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy

NCT00528268

In this single-center trial, we will evaluate the effects of NaPB on presymptomatic Spinal Muscular Atrophy (SMA) type I (cohort 1)and presymptomatic SMA type II (cohort 2) infants. A variety of outcome measures will be performed at each study visit to follow the course of the disease. Total duration of the study for type I infants will be 18 months, for type II infants, 24 months.

Spinal Muscular Atrophy

University of Utah22 participantsStarted Jul 2007

Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

NCT03744676

This is an open-label, multicenter, Phase 2 study to determine the safety, PK, and efficacy of lisocabtagene maraleucel (JCAR017) in subjects who have relapsed from, or are refractory to, two lines of immunochemotherapy for aggressive B-cell non-Hodgkin lymphoma (NHL) in the outpatient setting. Subjects will receive treatment with JCAR017 and will be followed for up to 2 years.

Lymphoma, Non-HodgkinLymphomaLymphoma, B-Cell+7 more

Juno Therapeutics, a Subsidiary of Celgene104 participantsStarted Nov 2018

Los Angeles, California, United States • Denver, Colorado, United States • Miami, Florida, United States +20 more locations

A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants

Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Find Trials by Condition in Salt Lake City

Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

Multicenter Hologic Tomosynthesis Study

An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension

Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer

Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis

A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine

FREEOAB Study for Overactive Bladder

Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System

Study of rSIFN-co for Patients With Advanced Solid Tumors

SurvivorLink: Scalability of an Electronic Personal Health Record

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Therapeutic Effects of Electrical Vestibular Stimulation (EVS) on Balance and Gait

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis